Document:

EX-10.15

 Exhibit 10.15 

EXECUTION COPY 
 EMPLOYMENT
AGREEMENT OF 
 MICHAEL FREED 

EMPLOYMENT AGREEMENT (this “Agreement”), effective as of July 16, 2016 (the “Effective Date”), between
Mirion Technologies (MGPI), Inc., a Delaware corporation (the “Company”), a wholly owned subsidiary within the worldwide Mirion Technologies corporate group (“Mirion”) and Michael Freed
(“Executive”). 
 In consideration of the mutual agreements set forth below and set forth in the Confidentiality, Non-Interference and Intellectual Property Agreement attached hereto as Exhibit A (the “Confidentiality Agreement”), and for other good and valuable consideration given by each party to this
Agreement to the other, the receipt and sufficiency of which are hereby acknowledged, the Company agrees to hire Executive and Executive agrees to serve the Company as an employee pursuant to the terms and subject to the conditions that follow. 

1. Employment. The Company hereby agrees to employ Executive, and Executive hereby agrees to accept employment with the Company,
upon the terms and conditions contained in this Agreement, effective on the Effective Date. Executive’s employment will be at-will, not for any specified period, and may be terminated at any time, with or
without Cause (as defined below) or advance notice, by either Executive, Mirion’s Chief Executive Officer (“CEO”), or the Company’s Board of Directors, subject to the provisions regarding termination set forth below in
Sections 7 and 8. No representative of Company, other than the CEO or the Board of Directors, has the authority to alter the at-will employment relationship. Any change to the
at-will employment relationship must be by specific, written agreement signed by Executive and either the Company’s CEO or its Board of Directors. Nothing in this Agreement is intended to or should be
construed to contradict, modify or alter this at-will relationship. 
 2. Duties.
During the Executive’s employment with Company (the “Employment Period”), Executive shall serve on a full-time basis as the Health Physics Division President (“Division President”) of the Company. Executive
shall initially report directly to the Mirion’s CEO. However, it is anticipated that in the fall of 2017 Executive will report directly to Mirion’s Chief Operating Officer (“COO”). Executive’s duties and
responsibilities as Division President shall include those duties customarily associated with an officer with a similar title, as reasonably may be assigned to him from time to time by the COO or CEO of Mirion or the Board of Directors of either the
Company or the Company’s ultimate parent, Mirion Technologies (TopCo) Ltd., a Jersey company (“TopCo”). Executive shall devote Executive’s full-time attention and energies and use Executive’s best efforts in his
employment with the Company. It is understood that during the Employment Period Executive may (i) engage in personal activities such as charitable, civic and trade industry work and (ii) manage Executive’s personal investments, so
long as such activities do not conflict with Executive’s duties and responsibilities hereunder. 
 [SIGNATURE PAGE TO THE EMPLOYMENT
AGREEMENT] 

 3. Compensation and Benefits. In consideration of entering into this Agreement
and as full compensation for Executive’s services hereunder, during the Employment Period, Executive shall receive the following compensation and benefits: 

(a) Base Salary. The Company shall pay to Executive a base salary (“Base Salary”) of Three Hundred Thousand U.S.
Dollars ($300,000) per year, less all applicable state and federal taxes and withholdings, payable in accordance with the payroll policies from time to time in effect at the Company. Executive’s Base Salary may be subject to increase (but not
decrease) on an annual basis as the Board of Directors shall determine in its sole and absolute discretion. 
 (b) Incentive Bonuses.
In addition to Base Salary, during the Employment Period, Executive shall be eligible to earn an annual incentive bonus based on the achievement of annual personal and corporate performance goals determined by the Board of Directors at the time of
the Board of Directors’ approval of the Company’s annual budget and payable in accordance with the Company’s policies in effect from time to time (the “Incentive Bonus”). The amount of the Incentive Bonus shall be
targeted at fifty percent (50%) of Executive’s Base Salary, is subject to increase of up to a maximum of one hundred percent (100%) of Base Salary and is subject to decrease, in each case, as determined by the Board of Directors in its sole
discretion. For FY 2017 (beginning July 1, 2016), Executive is guaranteed a minimum Incentive Bonus of at least $150,000, less taxes and withholdings (“FY 2017 Guaranteed Amount”). The FY 2017 Guaranteed Amount will be applied
to Executive’s required remittance for the Long-Term Equity Incentive. Any amount payable as an Incentive Bonus for FY 2017, to the extent such amount exceeds the FY 2017 Guaranteed Amount, will be paid out on or before September 30, 2017.

 (c) Long-Term Equity Incentive. Following commencement of Executive’s employment at a time determined by the Remuneration
Committee of TopCo in its reasonable discretion, the Remuneration Committee of TopCo will authorize TopCo to offer you the ability to subscribe to a number of A Ordinary Shares of TopCo approximately equivalent to one percent (1%) of the total
ordinary equity of TopCo, together with an amount of Loan Notes as determined by the Remuneration Committee of TopCo in its reasonable discretion, all subject to Executive’s remittance of the required monies and subject to Executive’s
execution of a Deed of Adherence as a Manager to that Investment Agreement dated November 18, 2014 (in the form required by that Investment Agreement), and related agreements. All shares are subject to the terms and conditions in the Investment
Agreement, the Amended and Restated Co-Investment Agreement dated June 17, 2016, and the Articles of Association of TopCo, as each may be amended from time to time. 

(d) Vacation. Executive shall be entitled to accrue up to four (4) weeks’ vacation per calendar year, to be accrued and used
in accordance with the usual vacation policies in effect at the Company. 

  
 2 

 (e) Deferred Compensation Plan. Executive will be eligible to participate in the
Company’s Deferred Compensation Plan, subject to the Plan’s eligibility requirements. 
 (f) Other Benefits. To the extent
allowed by applicable law, Executive shall participate in and be eligible to receive, but without duplication, all other benefits (i.e., benefits other than those of the types covered in Sections 3(a) - (e)) offered to senior executives of the
Company under and in accordance with the provisions of any employee benefit plan adopted or to be adopted by the Company other than any severance benefits offered to senior executives in accordance with any such plan. Except as set forth herein,
Executive shall not be entitled to any other benefits. 
 4. Reimbursement for Annual Executive Physical. During the
Employment Period, the Company will reimburse Executive for up to $3,000 used towards an annual Executive Physical. 
 5.
Reimbursement for Business Expenses. During the Employment Period, Executive shall be entitled to incur on behalf of the Company reasonable and necessary expenses in connection with Executive’s duties in accordance with
Company’s policies and the Company shall pay for or reimburse Executive for all such expenses upon presentation of proper receipts therefor. The Executive shall comply with such reasonable limitations and reporting requirements with respect to
such expenses as the Company may establish from time to time. · 
 6. Financial Planning Allowance. During the
Employment Period, the Company will provide Executive with up to $5,000 (less all taxes and withholdings) annually to cover costs for any personal financial and tax advisory costs and expenses incurred from time to time in connection with any matter
arising as a result of or in connection with the holding of shares, or any other investment from time to time in connection with any investment in the ‘group. 

7. Termination of Employment. Executive’s employment hereunder may be terminated as follows: 

(a) Automatically in the event of the death of Executive; 

(b) Unless prohibited by applicable law, at the option of the Company, by the Board of Directors by written notice to Executive or
Executive’s personal representative in the event of the Permanent Disability of Executive. As used herein, the term “Permanent Disability” shall mean a physical or mental incapacity or disability which renders Executive unable
to render the services required hereunder with or without reasonable accommodation (A) for one hundred twenty (120) days in any twelve (12) month period or (B) for a period of ninety (90) consecutive days; 

(c) At the option of the Company, by the Board of Directors at any time for Cause (as defined in Section 8(f)); 

  
 3 

 (d) At the option of the Company, by the Board of Directors at any time without Cause,
subject to the Company’s obligations under Section 8(c) hereof; or 
 (e) At the option of Executive, at any time, for any reason,
on sixty (60) days prior written notice to the Company, which 60 day prior notice shall be waivable at the sole option of the Company. 

(f) At the option of Executive for Good Reason (as defined in Section 8(g)), on sixty (60) days prior written notice to the Company,
which sixty (60) day prior notice shall be waivable at the sole option of the Company. 
 8. Payments Following Termination of
Employment. 
 (a) Death. Upon the termination of Executive’s employment due to death, Executive or his legal
representatives shall be entitled to receive (i) an amount equal to Executive’s Base Salary payable through the date of termination, (ii) a pro rata portion of Executive’s Incentive Bonus, if any, for the applicable period during
the fiscal year ending on the date of termination (which portion of the Incentive Bonus shall be reasonably determined by the Board of Directors as of the date of termination of employment), payable at the same time as such payment would be made had
the Executive continued his employment with the Company Executive or his legal representatives shall also be entitled to any accrued benefits which may be owing in accordance with the Company’s policies. 

(b) Permanent Disability. Upon the termination of Executive’s employment due to Permanent Disability, Executive or his legal
representatives shall be entitled to receive (i) an amount equal to Executive’s Base Salary payable through the date of termination, (ii) a pro rata portion of Executive’s Incentive Bonus, if any, for the applicable period during
the fiscal year ending on the date of termination (which portion of the Incentive Bonus shall be reasonably determined by the Board of Directors as of the date of termination of employment), payable at the same time as such payment would be made had
Executive continued Executive’s employment with the Company. Executive or his legal representatives shall also be entitled to any accrued benefits which may be owing in accordance with the Company’s policies. 

(c) Termination Without Cause. If Executive’s employment is terminated by the Company at any time during the Employment Period
without Cause, Executive shall be entitled to receive Executive’s Base Salary through the date of termination as well as any accrued benefits through the date of termination which may be owing in accordance with the Company’s policies. All
other Company obligations to Executive pursuant to this Agreement will become automatically terminated and completely extinguished. Upon termination without Cause, Executive will also be entitled to the following from the Company: (i) payment
of an amount equal to Executive’s then current Base Salary for a period of twelve (12) months, payable in accordance with the usual payroll policies in effect at the Company as if Executive was employed at the time, commencing on the first
payroll date occurring sixty (60) days from the date of termination; (ii) a pro rata portion of Executive’s Incentive Bonus, if 

  
 4 

 
any, for the applicable period during the fiscal year ending on the date of termination (which portion of the Incentive Bonus shall be reasonably determined by the Board of Directors at the end
of the applicable bonus period), payable at the same time as such payment would be made during Executive’s regular employment with the Company; and (iii) continued payment by the Company, for a period equal to the lesser of (A) twelve
(12) months from the date of termination and (B) such time that Executive commences employment with a new employer and becomes eligible to participate in that employer’s health care benefits plan, of the group health continuation coverage
premiums for Executive and Executive’s eligible dependents under Title X of the Consolidated Budget Reconciliation Act of 1985, as amended (“COBRA”) provided that Executive elects to continue and remains eligible for these
benefits under COBRA. Notwithstanding the foregoing, if the Company determines, in its sole discretion, that the payment of the COBRA premiums would result in a violation of the nondiscrimination rules of Section 105(h)(2) of the Internal
Revenue Code of 1986, as amended or any statute or regulation of similar effect (including but not limited to the 2010 Patient Protection and Affordable Care Act, as amended by the 2010 Health Care and Education Reconciliation Act), then in lieu of
reimbursing the COBRA premiums, the Company, in its sole discretion, may elect to instead pay Executive on the first day of each month, a fully taxable cash payment equal to the COBRA premiums for that month, subject to applicable tax withholdings
(such amount, the “Special Severance Payment”), for the remainder of the COBRA Payment Period. Executive may, but is not obligated to, use such Special Severance Payment toward the cost of COBRA premiums. 

(d) Termination for Cause or by Executive Without Good Reason. Except for Base Salary through the day on which Executive’s
employment was terminated and any accrued benefits which may be owing in accordance with the Company’s policies or applicable law, Executive shall not be entitled to receive severance or any other compensation, bonus or benefits after the last
date of employment with the Company upon the termination of Executive’s employment hereunder by the Company for Cause pursuant to Section 7(c) or upon Executive’s termination of employment hereunder pursuant to Section 7(e),
without Good Reason. 
 (e) Termination by Executive for Good Reason. Executive may voluntarily resign Executive’s position with
Company for Good Reason (as defined below), at any time on sixty (60) days’ advance written notice. In the event of Executive’s resignation for Good Reason, Executive will be entitled to receive Executive’s Base Salary through
the date of termination, and any accrued benefits through the date of termination which may be owing in accordance with the Company’s policies. All other Company obligations to Executive pursuant to this Agreement will become automatically
terminated and completely extinguished. Upon termination for Good Reason, Executive shall also be entitled to the following from the Company: (i) payment of an amount equal to Executive’s Base Salary for a period of twelve
(12) months, payable in accordance with the usual payroll policies in effect at the Company as if Executive was employed at the time, commencing on the first payroll date occurring sixty (60) days from the date of termination; (ii) a
pro rata portion of Executive’s Incentive Bonus, if any, for the applicable period during the fiscal year ending on the date of termination (which portion of the Incentive Bonus shall be reasonably determined by the Board of Directors at the
end of the applicable bonus period), payable at the same time as such payment would be made during Executive’s regular employment with the Company; and (iii) continued payment, for a period equal to the lesser of (A) twelve (12)
months from the date of termination and (B) such time that Executive commences employment with a new employer and becomes eligible to participate in that employer’s health care benefits plan, of the group health continuation coverage
premiums for Executive and Executive’s eligible dependents under Title X of the Consolidated Budget Reconciliation Act of 1985, as amended (“COBRA”), provided that Executive elects to continue and remains eligible for these
benefits under COBRA. Notwithstanding the foregoing, if the Company determines, in its sole discretion, that the payment of the COBRA premiums would result in a violation of the nondiscrimination rules of Section 105(h)(2) of the Internal
Revenue Code of 1986, as amended or any statute or regulation of similar effect (including but not limited to the 2010 Patient Protection and Affordable Care Act, as amended by the 2010 Health Care and Education Reconciliation Act), then in lieu of
reimbursing the COBRA premiums, the Company, in its sole discretion, may elect to instead pay Executive on the first day of each month, a fully taxable cash payment equal to the COBRA premiums for that month, subject to applicable tax withholdings
(such amount, the “Special Severance Payment”), for the remainder of the COBRA Payment Period. Executive may, but is not obligated to, use such Special Severance Payment toward the cost of COBRA premiums. 

  
 5 

 (f) Cause Defined. For purposes of this Agreement, the term “Cause”
shall mean that Executive: 
 (i) committed or engaged in an act of fraud, embezzlement, sexual harassment, or theft, in connection with
Executive’s duties for the Company or any subsidiary of the Company as determined in good faith by the Company’s Board of Directors; 

(ii) materially breached or defaulted on Executive’s obligations under any agreements between Executive and the Company or any subsidiary
of the Company, including but not limited to this Agreement or the Confidentiality Agreement (which breach or default, if reasonably capable of cure, is not cured within two (2) business days after written notice thereof is received by
Executive or, if reasonably capable of cure but not within two (2) business days, the Executive shall not have commenced cure in good faith within such two (2) business days and completed such cure as promptly as reasonably practical
thereafter); 
 (iii) is convicted of, or pleads nolo contendere with respect to, a felony; or 

(iv) engaged in an act of gross negligence or willful failure to perform Executive’s duties or responsibilities, including the failure to
follow in any material respect a lawful, properly adopted direction or written policy of the Board of Directors (which breach or default, if reasonably capable of cure, is not cured within ten (10) business days after written notice thereof or,
if reasonably capable of cure but not within ten (10) business days, the Executive shall not have commenced cure in good faith within such ten (10) business days and completed such cure as promptly as reasonably practical thereafter). 

  
 6 

 (g) Good Reason Defined. For purposes of this Agreement, the term “Good
Reason” shall mean in the absence of the written consent of Executive: 
 (i) a material reduction in Executive’s Base Salary
by the Company; 
 (ii) a material diminution in Executive’s authority, duties or responsibilities with respect to the Company, in each
case, from those contemplated in Section 2 (other than isolated actions not taken in bad faith and remedied by the Company within the cure period set forth below), provided this shall not include a change in Executive’s reporting structure
as set forth in this Agreement; 
 (iii) the requirement by the Company that Executive be based in an office which increases
Executive’s commute by more than twenty-five (25) miles in relation to Executive’s current commute to the Company’s facility in Smyrna, Georgia (where Executive currently works), located at 5000 Highlands Parkway, Suite 150,
Smyrna, Georgia 30082; or 
 (iv) any material breach by the Company of any material term or provision of this Agreement. 

Notwithstanding the foregoing, in the event that Executive provides written notice of termination for Good Reason in reliance upon this
Section 8(g), the Company shall have the opportunity to cure such circumstances within thirty (30) days of receipt of such notice. If Executive does not deliver to the Company a notice of termination within the thirty (30) day period
after Executive has knowledge that an event constituting Good Reason has occurred, such event will no longer constitute Good Reason. 
 (h)
Condition to Payment. All payments and benefits due to Executive under this Section 8 which are not otherwise required by law shall be contingent upon (i) execution by Executive (or Executive’s beneficiary or estate) of a
general release of all claims in a form prescribed by the Board of Directors and such general release becoming effective in accordance with its terms no later than sixty (60) days following Executive’s termination of employment, and
(ii) Executive’s continued adherence to the terms of the Confidentiality Agreement. 
 (i) No Other Severance. Executive
hereby acknowledges and agrees that, other than the severance payment described in Section 8(c) and (e) hereof, upon termination, Executive shall not be entitled to any other severance under any Company benefit plan or severance policy
generally available to the Company’s employees or otherwise. 

  
 7 

 (j) Survival. This Section 8 shall survive any termination or expiration of this
Agreement. 
 9. Application of Section 409A. Notwithstanding anything set forth in this
Agreement to the contrary, to the extent required to avoid the imposition of additional taxes and penalties under Section 409A of the Code (“Section 409A”), amounts payable under this Employment Agreement
will not be paid until Executive experiences a “separation of service” within the meaning of Section 409A. 
 (a) Furthermore,
to the extent that Executive is a “specified employee” within the meaning of Section 409A as of the date of Executive’s separation from service, no amount that constitutes a “deferral of compensation” (within the
meaning of Section 409A) which is payable on account of Executive’s separation from service shall be paid to Executive before the date (the “Delayed Payment Date”) which is first day of the seventh month after the date of
Executive’s separation from service or, if earlier, the date of Executive’s death following such separation from service. All such amounts that would, but for this Section 9(a), become payable prior to the Delayed Payment Date will be
accumulated and paid on the Delayed Payment Date. 
 (b) Company intends that income provided to Executive pursuant to this Agreement will
not be subject to taxation under Section 409A. The provisions of this Agreement shall be interpreted and construed in favor of satisfying any applicable requirements of Section 409A (including provisions exempting certain payments from
Section 409A). However, Company does not guarantee any particular tax effect for income provided to Executive pursuant to this Agreement. 

(c) The reimbursement of expenses or in-kind benefits provided pursuant to this Agreement shall be
subject to the following conditions: (i) the expenses eligible for reimbursement or in-kind benefits in one taxable year shall not affect the expenses eligible for reimbursement or in-kind benefits in any other taxable year; (ii) the reimbursement of eligible expenses or in-kind benefits shall be made promptly, subject to Company’s applicable
policies, but in no event later than the end of the year after the year in which such expense was incurred; and (iii) the right to reimbursement or in-kind benefits shall not be subject to liquidation or
exchange for another benefit. 
 (d) For purposes of Section 409A, the right to a series of installment payments under this Agreement
shall be treated as a right to a series of separate payments. 
 10. Confidentiality Agreement. Simultaneous with the
execution and delivery of this Agreement, the Company and the Executive shall execute and deliver the Confidentiality Agreement attached hereto as Attachment A incorporated herein by reference. The Confidentiality Agreement shall survive any
termination of this Agreement in accordance with the terms of the Confidentiality Agreement. 

  
 8 

 11. Indemnification. The Company will indemnify Executive in his capacity as
an officer of the Company to the fullest extent permitted by the certificate of incorporation and bylaws of the Company. 
 12.
Withholding Taxes. Executive acknowledges and agrees that the Company may directly or indirectly withhold from any payments under this Agreement all federal, state, city or other taxes that will be required pursuant to any law or
governmental regulation. 
 13. Effect of Prior Agreements. This Agreement, together with the Confidentiality Agreement and
the Executive Incentive Plan and related participation unit award documentation constitute the sole and entire agreements and understandings between Executive and the Company with respect to the matters covered hereby and thereby, and there are no
other promises, agreements, representations, warranties or other statements between Executive and the Company in respect to such matters not expressly set forth in these agreements. These agreements supersede all prior and contemporaneous
agreements, understandings or other arrangements, whether written or oral, concerning the subject matter thereof. 
 14.
Notices. Any notice required, permitted, or desired to be given pursuant to any of the provisions of this Agreement shall be deemed to have been sufficiently given or served for all purposes when faxed, when delivered by hand, or
received by registered or certified mail, postage prepaid, or by nationally recognized overnight courier service addressed to the party to receive such notice at the following address or any other address substituted therefor by notice pursuant to
these provisions: 
 If to the Companies, at: 

Mirion Technologies (MGPI), Inc. 

c/o Mirion Technologies, Inc. 

3000 Executive Parkway, Suite 222 

San Ramon, CA 94583 
 Attention:
General Counsel 
 Telephone: (925) 543-0800 

Facsimile: (925) 543-0808 

with copies to: 
 Charterhouse
Capital Partners LLP 
 7th Floor, Warwick Court 

Paternoster Square 
 London 

EC4M7DX 
 Attn: Chris Warren

 Telephone:         +44 (0)20 7334 5300 

Facsimile:           +44 (0)20 7334 5344 

  
 9 

 If to Executive, at: 

Michael Freed 
 138 Peachtree
Hills Ave NE 
 Atlanta, GA 30305 

Telephone: 860-705-6632 

15. Assignability. The obligations of Executive may not be delegated and Executive may not, without the Company’s written
consent thereto, assign, transfer, convey, pledge, encumber, hypothecate or otherwise dispose of this Agreement or any interest herein. Any such attempted delegation or disposition shall be null and void and without effect. The Company and Executive
agree that this Agreement and all of the Company’s rights and obligations hereunder may be assigned or transferred by the Company to and may be assumed by and become binding upon and may inure to the benefit of any affiliate of or successor to
the Company. The term “successor” shall mean any other corporation or other business entity which, by merger, consolidation, purchase of the assets, or otherwise, acquires all or a material part of its assets. Any assignment by the Company
of its rights or obligations hereunder to any affiliate of or successor to the Company shall not be a termination of employment for purposes of this Agreement. 

16. Modification. This Agreement may not be modified or amended except in writing signed by the parties. No term or condition of
this Agreement will be deemed to have been waived except in writing by the party charged with waiver. A waiver will operate only as to the specific term or condition waived and will not constitute a waiver for the future or act on anything other
than that which is specifically waived. 
 17. Governing Law. This Agreement has been executed and delivered in the State of
Georgia and its validity, interpretation, performance and enforcement will be governed by the laws of Georgia, applicable to contacts made and to be performed entirely within that state. 

18. Severability. All provisions of this Agreement are intended to be severable. In the event any provision or restriction
contained herein is held to be invalid or unenforceable in any respect, in whole or in part, such finding will in no way affect the validity or enforceability of any other provision of this Agreement. The parties hereto further agree that any such
invalid or unenforceable provision will be deemed modified so that it will be enforced to the greatest extent permissible under law, and to the extent that any court of competent jurisdiction determines any restriction herein to be unreasonable in
any respect, such court may limit this Agreement to render it reasonable in the light of the circumstances in which it was entered into and specifically enforce this Agreement as limited. 

19. No Waiver. Except as specifically contemplated in this Agreement, no course of dealing or any delay on the part of the
Company or Executive in exercising any rights hereunder shall operate as a waiver of any such rights. No waiver of any default or breach of this Agreement shall be deemed a continuing waiver of any other breach or default. 

  
 10 

 20. Counterparts. This Agreement may be executed in one or more counterparts,
each of which shall be deemed to be an original by the party executing the same but all of which together will constitute one and the same instrument. 

21. Binding Arbitration. 

(a) Generally. Executive and the Company hereby agree that any controversy or claim arising out of or relating to this Agreement, the
employment relationship between Executive and the Company, or the termination thereof, including the arbitrability of any controversy or claim, which cannot be settled by mutual agreement will be finally settled by binding arbitration in accordance
with the Federal Arbitration Act (or if not applicable, the applicable state arbitration law) as follows: Any party who is aggrieved will deliver a notice to the other party setting forth the specific points in dispute. Any points remaining in
dispute twenty (20) days after the giving of such notice may, upon ten (10) days’ notice to the other party, be submitted to arbitration in Atlanta, Georgia, to the American Arbitration Association, before a single arbitrator
appointed in accordance with the Employment Arbitration Rules and Mediation Procedures of the American Arbitration Association (“AAA”) (available at www.adr.org), as such procedures and rules may be amended from time to time
and modified only as herein expressly provided. The arbitrator may enter a default decision against any party who fails to participate in the arbitration proceedings. The parties acknowledge and agree that they retain the right to seek injunctive
relief pursuant to the AAA Rules or the Georgia Arbitration Code. Any provisional remedy which would be available from a court of law shall be available from the arbitrator to the parties to this Agreement pending arbitration. Either party may make
an application to the arbitrator seeking injunctive relief to maintain the status quo until such time as the arbitration award is rendered or the controversy is otherwise resolved. 

(b) Binding Effect. The decision of the arbitrator on the points in dispute will be final, unappealable and binding, and judgment on the
award may be entered in any court having jurisdiction thereof. The parties agree that this provision has been adopted by the parties to rapidly and inexpensively resolve any disputes between them and that this provision will be grounds for dismissal
of any court action commenced by either party with respect to this Agreement, other than post-arbitration actions seeking to enforce an arbitration award. 

(c) Fees and Expenses. Except as otherwise provided in this Agreement or by law, the arbitrator will be authorized to apportion its fees and
expenses as the arbitrator deems appropriate and the Company will bear the fees and expenses of the arbitration but the arbitrator will be authorized to award the prevailing party its fees and expenses (including attorney’s fees). In the
absence of such apportionment or award, each party will bear the fees and expenses of its own attorney. 
 (d) Confidentiality. The parties
will keep confidential, and will not disclose to any person, except as may be required by law, the existence of any controversy under this Section 21, the referral of any such controversy to arbitration or the status or resolution thereof. In
addition, the confidentiality restrictions set forth in the Confidentiality Agreement shall continue in full force and effect. 

  
 11 

 (e) Waiver. Executive acknowledges that arbitration pursuant to this agreement
includes all controversies or claims of any kind (e.g., whether in contract or in tort, statutory or common law, legal or equitable) now existing or hereafter arising under any federal, state, local or foreign law, including, but not limited to, the
Age Discrimination in Employment Act, Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1866, the Employee Retirement Income Security Act, the Family and Medical Leave Act, the Americans With Disabilities Act and all similar
federal, state and local laws, and Executive hereby waives all rights thereunder to have a judicial tribunal and/or a jury determine such claims. 

(f) Acknowledgment. Executive acknowledges that before entering into this Agreement, Executive has had the opportunity to consult with
any attorney or other advisor of Executive’s choice, and that this provision constitutes advice from the Companies to do so if Executive chooses. Executive further acknowledges that Executive has entered into this Agreement of Executive’s
own free will, and that no promises or representations have been made to Executive by any person to induce Executive to enter into this Agreement other than the express terms set forth herein. Executive further acknowledges that Executive has read
this Agreement and understands all of its terms, including the waiver of rights set forth in Section 21(e). 
 22. Counsel Fees
of Executive. The Company agrees to pay up to a total of five thousand U.S. dollars ($5,000) of the reasonable actual fees and expenses of counsel to Executive incurred in connection with the negotiation, execution and delivery of this
Agreement and the other agreements referenced herein. 

  
 12 

 IN WITNESS WHEREOF, the parties have caused this Agreement to be executed as of the day
written above. 
  

			
	MIRION TECHNOLOGIES (MGPI), INC.
		
	By:	 	 /s/ Thomas D. Logan

		 	Name:Thomas D. Logan
		 	Title:Chief Executive Officer

  

	
	EXECUTIVE
	
	 /s/ Michael Freed

	Michael Freed

 [SIGNATURE PAGE TO THE EMPLOYMENT AGREEMENT] 

 EXHIBIT A 

CONFIDENTIALITY, NON-INTERFERENCE AND 

INTELLECTUAL PROPERTY AGREEMENT 

  
 [SIGNATURE PAGE TO FREED
CONFIDENTIALITY, NON-INTERFERENCE AND IP AGREEMENT] 

 CONFIDENTIALITY, NON-INTERFERENCE AND
INTELLECTUAL PROPERTY AGREEMENT (this “Agreement”), dated as of July 16, 2016 (the “Effective Date”), among Mirion Technologies (MGPI), Inc., a Delaware corporation (the “Company”) and, for
purposes of this Agreement, any other direct or indirect subsidiary of the Company, the “Companies”), and Michael Freed (“Executive”). 

WHEREAS, for the purpose of this Agreement, the Company and any direct and indirect subsidiaries of the Company will be collectively
referred to as the “Companies.” 
 WHEREAS, the Companies are currently engaged in the business of, among other things,
radiation measurement and detection, including (but not limited to) designing, manufacturing, distributing, and selling products that detect, monitor and identify radiation, as well as other products which protect people and goods from nuclear and
radiological risks. 
 WHEREAS, Executive has been offered employment with the Company, and has entered into an employment agreement
dated of even date herewith with the Company (the “Employment Agreement”). In such role, Executive will receive specific confidential information and training relating to the businesses of the Companies, which confidential
information and training is necessary to enable Executive to perform Executive’s duties and to receive future compensation. Executive will play a significant role in the development and management of the businesses of the Companies and will be
entrusted with the Companies’ confidential information relating to the Companies, the Companies’ customers, manufacturers, distributors and others. 

WHEREAS, Executive acknowledges that during the course of Executive’s employment with the Company, Executive will be involved in
the current and future businesses of the Companies, as set forth above. 
 WHEREAS, it is a condition to the commencement of
Executive’s employment by the Company that Executive execute and deliver this Agreement. 
 NOW, THEREFORE, it is mutually
agreed as follows: 
 1. Confidentiality. 

(a) Executive shall not, during the term of Executive’s employment with the Company or at any time thereafter, directly or indirectly,
divulge, use, furnish, disclose, exploit or make available to any person or entity, whether or not a competitor of the Companies, any Unauthorized disclosure of Confidential Information. 

As used herein, the term: 

“Confidential Information” shall mean trade secrets, confidential or proprietary information, and all other information,
documents or materials, relating to, owned, developed or possessed by either of the Companies, whether in tangible or intangible form. Confidential Information includes, but is not limited to, (i) financial

  
 [SIGNATURE PAGE TO FREED
CONFIDENTIALITY, NON-INTERFERENCE AND IP AGREEMENT] 

 
information, (ii) products, (iii) product and service costs, prices, profits and sales, (iv) new business, technical or other ideas, proposals, plans and designs, (v) business
strategies, (vi) product and service plans, (vii) marketing plans and studies, (viii) forecasts, (ix) budgets, (x) projections, (xi) computer programs, (xii) data bases and the documentation (and information contained
therein), (xiii) computer access codes and similar information, (xiv) source codes, (xv) know-how, technologies, concepts and designs, including, without limitation, patent applications,
(xvi) research projects and all information connected with research and development efforts, (xvii) records, (xviii) business relationships, methods and recommendations, (xix) existing or prospective client, customer, vendor and
supplier information (including, but not limited to, identities, needs, transaction histories, volumes, characteristics, agreements, prices, identities of individual contacts, and spending, preferences or habits), (xx) training manuals and similar
materials used by the Companies in conducting its business operations, (xxi) skills, responsibilities, compensation and personnel files of employees, directors and independent contractors of either of the Companies, (xxii) competitive
analyses, (xxiii) contracts with other parties, (xxiv) product formulations, and (xxv) other confidential or proprietary information that has not been made available to the general public by the senior management of either of the
Companies. Confidential Information shall not include information that (I) is or becomes generally available to the public through no act or omission on the part of Executive, (II) is hereafter received on a
non-confidential basis by Executive from a third party who has the lawful right to disclose such information, or (III) Executive is required to disclose pursuant to court order or law. 

“Unauthorized” shall mean: (i) in contravention of the policies or procedures of either of the Companies;
(ii) otherwise inconsistent with any measures taken by either of the Companies to protect its interests in the Confidential Information; (iii) in contravention of any lawful instruction or directive, either written or oral, of the Board of
Directors, or an officer or employee of either of the Companies empowered to issue such instruction or directive; (iv) in contravention of any duty existing under law or contract; or (v) to the detriment of either of the Companies. 

(b) Executive further agrees to take all reasonable measures to prevent unauthorized persons or entities from obtaining or using Confidential
Information. Promptly upon request or upon termination, for any reason, of Executive’s employment with the Companies, Executive agrees to deliver to the Companies all property and materials within Executive’s possession or control which
belong to either of the Companies or which contain Confidential Information. 
 Nothing in this Agreement shall be construed as a waiver by
any of the Companies of any rights that they might have under any applicable state and federal statutes, laws, or common law doctrines that afford protection to trade secrets and other business information/materials (“Trade Secret Laws”).
It is understood and agreed that Executive may never use or divulge any information/materials that constitute a “trade secret” of any of the Companies (except in furtherance of Executive’s duties as an employee of the Company) under
the applicable Trade Secret Laws. 

  
 16 

 2. Non-Interference with Employees. 

Executive covenants and agrees that, during Executive’s employment with the Company, and for a period of two (2) years after the termination of
Executive’s employment with the Company (whether voluntarily or involuntarily, and whether with or without Cause), Executive will not (except on behalf of the Companies) directly or indirectly: (a) solicit, induce, or encourage any
“Covered Employee” (defined below) to terminate his or her employment with the any of the Companies; (b) reemit, entice, or encourage any Covered Employee to accept employment with any person or entity (other than one of the
Companies); or (c) hire or attempt to hire any Covered Employee for or on behalf of any person or entity (other than one of the Companies). As used herein, the term “Covered Employee” means and includes: (i) anyone employed in or
working for the Company’s Health Physics Division; (ii) any person employed by one or more of the Companies who reported to Executive (directly or indirectly) during Employee’s tenure with the Companies; (iii) any employee of one
or more of the Companies with whom Executive had contact or dealings during and by virtue of Executive’s employment with the Company; and (iv) any employee of one or more of the Companies about whom Executive learned or with whom Executive
became familiar during and by virtue of Executive’s employment with the Company. 
 3.
Non-Solicitation of Customers and Non-Competition. 

(a) Executive covenants and agrees that, during Executive’s employment with the Company, and for a period of one (1) year after the
termination of Executive’s employment (whether voluntarily or involuntarily, and whether with or without Cause), Executive will not (except on behalf of the Company) solicit or attempt to solicit (directly or by assisting others) any
“Covered Customer” (as defined below) with a view toward selling or providing any “Competitive Products or Services” (as defined below) for or on behalf of any person or entity other than the Companies. As used herein,
“Covered Customer” means and includes any actual or prospective customer of any of the Companies: (i) with whom/which Executive dealt on behalf of one or more of the Companies; or (ii) whose dealings with the Company (or any of
the Companies) were coordinated or supervised by Executive during Executive’s employment with the Company; or (iii) about whom/which Executive obtained Confidential Information in the ordinary course of business as a result of
Executive’s association with the Companies; or (iv) who/which received products or services from one or more of the Companies, the sale or provision of which resulted in compensation, commissions, or earnings for Executive within two years
prior to the termination of Executive’s employment with the Company. As used herein, “Competitive Products or Services” shall mean and include products and/or services that are competitive with those offered and/or provided by the
Companies. 
 (b) Executive covenants and agrees that, during Executive’s employment with the Company, and for a period of one
(1) year after termination of Executive’s employment with the Company (whether voluntarily or involuntarily, and whether with or without Cause), Executive will not (directly or indirectly) within the “Territory” (as defined
below): (i) carry on or work in furtherance of any “Competitive 

  
 17 

 
Business” (as defined below) in circumstances where Executive’s duties and responsibilities are the same as or substantially similar to the duties and responsibilities he performed for
the Company; or (ii) perform for any Competitive Business any services and/or duties that are the same as or substantially similar to any of the services and/or duties which he performed for the Company. As used herein, the
“Territory” shall mean and include the area encompassed within a 50-mile radius of the Executive’s principal office at the time of Executive’s termination. As used herein, the term
“Competitive Business” shall mean and include any person, corporation, association, organization, and/or entity who/which is in the business of manufacturing, designing, selling, distributing, and/or providing “Competitive Products or
Services” (as defined above). Provided, however, that nothing contained herein shall be construed as prohibiting Executive from holding any position or performing any services for any separate identifiable division, department, or unit of a
Competitive Business if that department, division, or unit is not, itself, an actual or potential competitor of the Company, and if the Executive’s duties and/or services do not relate to any Competitive Products or Services (as defined above).

 (c) Executive covenants and agrees that, during Executive’s employment with the Company, and for a period of one (1) year after
termination of Executive’s employment with the Company (whether voluntary or involuntary, and whether with or without Cause), Executive will not (directly or indirectly), within the “Mirion-Territory” (as defined below): (a) become
employed by or work for any of the “Restricted Competitors” (as defined below) in any position or capacity where Executive’s duties and/or responsibilities are the same as or substantially similar to the duties and responsibilities
Executive performed for the Company; or (b) perform or provide any services which are the same as or substantially similar to the services which Executive performed or provided for the Company, for or on behalf of any of the Restricted
Competitors. As used herein, the term “Mirion-Territory” shall mean and include any and all geographic territories and areas where the Companies operate and do business. As used herein, “Restricted Competitors” shall mean and
include each of the following: (i) Landauer, Inc.; (ii) Ludlum Measurements, Inc.; (iii) Saphymo GmbH (part of the Bertin Technologies group); (iv) General Atomics; (v) Overhoff Technology Corporation or Technical Associates;
(vi) Radico; (vii) Rotem Industries; (viii) Rapiscan Systems; (ix) Smiths Detection, and (x) Thermo Fisher Scientific Inc. Provided, however, that nothing contained herein shall be construed as prohibiting Executive from holding
any position with or performing any services for: (A) any Restricted Competitor that has ceased to be a “Competitive Business” (as defined above); or (B) any separate identifiable division, department, or unit of a Restricted
Competitor if that department, division, or unit is not, itself, an actual or potential competitor of the Company, and if Executive’s duties and/or services do not relate to any “Competitive Products or Services” (as defined above).

 (d) Notwithstanding any contrary terms or conditions set forth in this Agreement or the Employment Agreement executed contemporaneously
herewith, the following terms and conditions in this section 3(d) shall apply with respect to the covenants set forth in sections 3(a), 3(b), and 3(c) above (hereinafter “Section 3 Covenants”) in the event that: (1) the Company
terminates Executive’s employment without “Cause” (as defined in the Employment Agreement); or (2) Executive resigns for “Good Reason” (as defined in the Employment Agreement). 

  
 18 

 (i) If any such circumstances come to fruition, the Company shall have the option, in its
sole discretion, to either hold Executive to the Section 3 Covenants, or to release Executive from the Section 3 Covenants. The Company shall provide Executive with written notice of its election in accordance with Section 14 of the
Employment Agreement no later than fourteen (14) days after Executive’s date of termination, and Executive shall be legally bound by each of the Section 3 Covenants without the need for Company to pay any additional consideration
until such notice is received by him or until the fourteen (14) day period expires. 
 (ii) Should the Company elect to hold Executive
to the Section 3 Covenants, then the Company shall pay Executive an amount equal to fifty percent (50%) of any amount that is or would otherwise be due to Executive under Section 8(c) or Section 8(e) of the Employment Agreement,
whichever is applicable (hereinafter “Additional Consideration”). Such Additional Consideration shall be paid to Executive in the time and manner described in Section 8(c) of the Employment Agreement. Any refusal by Executive to
accept some or all of the Additional Consideration shall not operate to relieve Executive of Executive’s binding legal obligation to adhere to the Section 3 Covenants. In addition, the Company also shall retain the option to hold Executive
to the Section 3 Covenants even if Executive forgoes or forfeits the payments or amounts that would otherwise be due to Executive under Section 8(c) or Section 8(e) of the Employment Agreement (whichever is applicable) by failing or
refusing to execute the “general release of all claims” that is referenced in Section 8(h) of the Employment Agreement. 
 e)
In the event that Executive’s employment is terminated for “Cause” (as defined in the Employment Agreement), or Executive quits or resigns without “Good Reason” (as defined in the Employment Agreement), or Executive’s
employment is terminated due to Executive’s own election not to renew the Employment Agreement, then Executive shall automatically be legally bound and obligated to adhere to each of the Section 3 Covenants, and no additional consideration
or payments shall be due or owing for Executive’s adherence to said Covenants. 
 2. Intellectual Property. Executive agrees
that during the term of Executive’s employment with the Company, any and all inventions, discoveries, innovations, writings, domain names, improvements, trade secrets, designs, drawings, business processes, secret processes and know-how, whether or not patentable or q copyright or trademark, which Executive may create, conceive, develop or make, either alone or in conjunction with others and related or in any way connected with the
Companies, their strategic plans, products, processes, apparatus or business now or hereafter carried on by the Companies (collectively, “Inventions”), shall be fully and promptly disclosed to the Company and shall be the sole and
exclusive property of the Companies (as they shall determine) as against Executive or any of Executive’s assignees: Regardless of the status of Executive’s employment by the Company, Executive and Executive’s heirs, assigns

  
 19 

 
and representatives shall promptly assign to the Company any and all right, title and interest in and to such Inventions made during the term of Executive’s employment by the Company or
within six months thereafter. Except as set forth on Schedule 1 to this Agreement, there are no Inventions with respect to any of the Companies conceived of, developed or made by Executive before the date of this Agreement. 

Whether during or after Executive’s employment with the Company, Executive further agrees to execute and acknowledge all papers and to
do, at the Company’s expense, any and all other things necessary for or incident to the applying for, obtaining and maintaining of such letters patent, copyrights, trademarks or other intellectual property rights, as the case may be, and to
execute, on request, all papers necessary to assign and transfer such Inventions, copyrights, patents, patent applications and other intellectual property rights to the Company, their successors and assigns (as they shall determine). In the event
that the Company is unable, after reasonable efforts and, in any event, after ten (10) business days, to secure Executive’s signature on a written assignment to the Company, of any application for letters patent, trademark registration or
to any common law or statutory copyright or other property right therein, whether because of Executive’s physical or mental incapacity, or for any other reason whatsoever, Executive irrevocably designates and appoints the Secretary of the
Company as Executive’s attorney-in-fact to act on Executive’s behalf to execute and file any such applications and to do all lawfully permitted acts to further
the prosecution or issuance of such assignments, letters patent, copyright or trademark. 
 3. No Right to Continued Employment.
Nothing in this Agreement shall confer upon Executive any right to continue in the employ of the Company or shall interfere with or restrict in any way the right of the Company, subject to the terms of the Employment Agreement, to discharge
Executive at any time for any reason whatsoever, with or without cause. 
 4. No Conflicting Agreements. Executive warrants that
Executive is not bound by the terms of a confidentiality agreement, non-competition or other agreement with a third party that would conflict with Executive’s obligations hereunder or under the Employment
Agreement. 
 5. Remedies. 

(a) In the event of breach or threatened breach by Executive of any provision hereof, the Company (and/or any of the Companies) shall be
entitled to (i) temporary, preliminary and permanent injunctive relief and without the posting of any bond or other security, (ii) damages and. an equitable accounting of all earnings, profits and other benefits arising from such
violation, (iii) recovery of all attorney’s fees and costs incurred by the Companies in obtaining such relief, (iv) cessation of, and repayment by Executive to the Companies of, any severance benefits payable or paid to Executive
pursuant to any agreement with the Companies, including pursuant to any employment, stock repurchase, severance or benefit agreement, plan or program of any of the Companies or between Executive and any of the Companies, and (v) any other legal
and equitable relief to which any of Companies may be entitled, including any and all 

  
 20 

 
monetary damages which the Companies may incur as a result of said breach or threatened breach. The Companies may pursue any remedy available, including declaratory relief, concurrently or
consecutively in any order, and the pursuit of one such remedy at any time will not be deemed an election of remedies or waiver of the right to pursue any other remedy. 

(b) The period of time during which the restrictions set forth in Sections 2 and 3 hereof will be in effect will be extended by the length of
time during which Executive is in breach of the terms of those provisions as determined by any court of competent jurisdiction on the Company’s application for injunctive relief. 

6. Early Resolution Conference. This Agreement is understood to be clear and enforceable as written and is executed by both parties on
that basis. However, should the Company or Executive determine to later challenge any provision as unclear, unenforceable or inapplicable to any activity, the Company or Executive will first notify each other in writing and meet with a
representative of the Company and a neutral mediator (if the Company elects to retain one at their expense) to discuss resolution of any dispute between the parties with respect to such challenge. Executive will provide this notification at least
fourteen (14) days before Executive engages in any activity on behalf of a Restricted Competitor or engages in other activity that could foreseeably fall within a questioned restriction. · 

7. Successors and Assigns. This Agreement shall be binding upon Executive and Executive’s heirs, assigns and representatives and
the Company and its successors and assigns, including without limitation any entity to which substantially all of the assets or the business of the Company are sold or transferred. The obligations of Executive are personal to Executive and shall not
be assigned by Executive. 
 8. Severability. It is expressly agreed that if any restrictions set forth in this Agreement are found
by any court having jurisdiction to be unreasonable because they are too broad in any respect, then and in each such case, the remaining provisions herein contained shall, nevertheless, remain effective, and this Agreement, or any portion hereof,
shall be considered to be amended, so as to be considered reasonable and enforceable by such court, and the court shall specifically have the right to restrict the time period or the business or geographical scope of such restrictions to any portion
of the time period, business or geographic areas to the extent the court deems such restriction to be necessary to cause the covenants to be enforceable and, in such event, the covenants shall be enforced to the extent so permitted and the remaining
provisions shall be unaffected thereby. In such event, the Parties agree to execute all documents necessary to evidence such amendment so as to eliminate or modify any such unreasonable provision in order to carry out the intent of this Agreement
insofar as possible and to render this Agreement enforceable in all respects as so modified. 
 9. Notices. Any notice required or
permitted to be given under this Agreement shall be in writing and be deemed given when delivered by hand or received by registered or certified mail, postage prepaid, or by nationally reorganized overnight courier service addressed to the party to
receive such notice at the following address or any other address substituted therefor by notice pursuant to these provisions: 

  
 21 

 If to the Company, at: 

Mirion Technologies (MGPI), Inc. 

c/o Mirian Technologies, Inc. 

3000 Executive Parkway, Suite 222 

San Ramon, CA 94583 
 Attention:
General Counsel 
 Telephone: (925) 543-0800 

Facsimile: (925) 543-0808 

with copies to: 
 Charterhouse
Capital Partners LLP 
 7th Floor, Warwick Court 

Paternoster Square 
 London
EC4M7DX 
 Attn: Chris Warren 

Telephone: +44 (0)20 7334 5300 

Facsimile: +44 (0)20 7334 5344 

If to Executive, at: 
 Michael
Freed 
 138 Peachtree Hills Ave NE 

Atlanta, GA 30305 
 Telephone: 860-705-6632 
 10. Amendment. No provision of this
Agreement may be modified, amended, waived or discharged in any manner except by a written instrument executed by the Company and Executive. 

11. Entire Agreement. This Agreement constitutes the entire agreement of the parties hereto with respect to the subject matter
hereof, and supersedes all prior agreements and understandings of the parties hereto, oral or written, with respect to the subject matter hereof, however, if any portion of this Agreement is determined to be unenforceable by a court of law, then
solely the appropriate conflicting provisions of any other agreement binding upon Executive shall control. 
 12. Waiver, etc.
The failure of the parties to enforce at any time any of the provisions of this Agreement shall not be deemed or construed to be a waiver of any such provision, nor in any way affect the validity of this Agreement or any provision hereof or the
right of the parties to enforce thereafter each and every provision of this Agreement. No waiver of any breach of any of the provisions of this Agreement by the parties shall be effective unless set forth in a written instrument executed by the
party at issue, and no waiver of any such breach shall be construed or deemed to be a waiver of any other or subsequent breach. 

  
 22 

 13. Applicable Law. This Agreement shall be governed by and construed in
accordance with the laws of the State of Georgia applicable to contracts made and to be wholly performed therein without reference to conflicts of law principles, except as otherwise provided. 

14. Enforcement. If any Party shall institute legal action to enforce or interpret the terms and conditions of this Agreement or
to collect any monies under it, the exclusive venue for any such action shall be a court of competent jurisdiction (state or federal) in Atlanta, Georgia. Executive irrevocably consents to the jurisdiction of the courts located in the State of
Georgia for all suits or actions arising out of this Agreement. Each Party hereto waives to the fullest extent possible, any and all defenses relating to personal jurisdiction and/or inconvenient forum, and each of the Parties agrees that a final
judgment in any action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. 

[THE REMAINDER OF THIS PAGE LEFT INTENTIONALLY BLANK] 

  
 23 

 IN WITNESS WHEREOF, the parties have caused this Agreement to be executed as of the
day written above. 
  

			
	MIRION TECHNOLOGIES (MGPI), INC.
		
	By:	 	 /s/ Thomas D. Logan

		 	Name:Thomas D. Logan
		 	Title:Chief Executive Officer

  

	
	EXECUTIVE
	
	 /s/ Michael Freed

	Michael Freed

  

  
 [SIGNATURE PAGE TO FREED
CONFIDENTIALITY, NON-INTERFERENCE AND IP AGREEMENT] 

 Schedule 1 

Inventions 
 None. 

 

  
 [SIGNATURE PAGE TO FREED
CONFIDENTIALITY, NON-INTERFERENCE AND IP AGREEMENT]EX-10.16

 Exhibit 10.16 

FORM OF 
DIRECTOR NOMINATION AGREEMENT 

THIS DIRECTOR NOMINATION AGREEMENT (this “Agreement”) is made and entered into as of
[                    ], 2021 (the “Effective Time”), by and between Mirion Technologies, Inc., a Delaware corporation (f/k/a GS
Acquisition Holdings Corp II) (the “Company”), and CCP IX LP No. 1, CCP IX LP No. 2, CCP IX Co-Investment LP and CCP IX Co-Investment
No. 2 LP (collectively, the “Charterhouse Parties”), each acting by its general partner, Charterhouse General Partners (IX) Limited. 

WHEREAS, the Company has consummated the business combination and the other transactions (collectively, the “Transactions”)
contemplated by the Business Combination Agreement, dated as of June 17, 2021 (the “BCA”), by and among the Company, Mirion Technologies (TopCo), Ltd., a Jersey private company limited by shares, and the other parties thereto;

 WHEREAS, the Company desires that, after giving effect to the Transactions, the Charterhouse Parties will, subject to the terms of this
Agreement, continue to have a right to representation on the board of directors of the Company (the “Board”); 
 WHEREAS,
pursuant to Section 7.02 of the BCA, [                ] was named as a director by the Charterhouse Parties and elected to the Board by the stockholders of the
Company at the SPAC Special Meeting (as defined in the BCA); and 
 WHEREAS, in furtherance of the foregoing, the Company desires that the
Charterhouse Parties have certain director nomination rights with respect to the Company, and the Company desires to provide the Charterhouse Parties with such rights, in each case, on the terms and conditions set forth herein. 

NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and
sufficient of which are hereby acknowledged, each of the parties to this Agreement agrees as follows: 
 ARTICLE 1 

NOMINATION RIGHT 

Section 1.01.    Board Nomination Right. Subject to Section 1.02, from the Effective Time until the
termination of this Agreement in accordance with its terms: 
 (a)    At every meeting of the Board or a committee
thereof, or action by written consent, at or by which directors of the Company are appointed by the Board or are nominated to stand for election and elected by stockholders of the Company, the Charterhouse Parties shall have the right (but not the
obligation) to appoint or nominate for election to the Board, as applicable, one (1) individual, to serve as director of the Company (the “CCP Director”). As of the date hereof, the Charterhouse Parties designate [
            ] as the initial CCP Director. The Company shall use reasonable best efforts to take all actions necessary (including, without limitation, calling special meetings of the Board
and the stockholders of the Company and recommending, 

 
supporting and soliciting proxies) to ensure that: (i) the CCP Director is included in the Board’s slate of nominees to the stockholders of the Company for the election of directors of
the Company and recommended by the Board at any meeting of stockholders called for the purpose of electing directors of the Company; and (ii) the CCP Director, if up for election, is included in the proxy statement prepared by management of the
Company in connection with the Company’s solicitation of proxies or consents in favor of the foregoing for every meeting of the stockholders of the Company called with respect to the election of members of the Board, and at every adjournment or
postponement thereof, and on every action or approval by written resolution of the stockholders of the Company or the Board with respect to the election of directors of the Company; provided, that if the Charterhouse Parties inform the
Company in writing that they do not wish to appoint or nominate a CCP Director, then the Company shall not be in breach of its obligations under this Section 1.01(a). 

(b)    If the CCP Director ceases to serve on the Board for any reason, the Charterhouse Parties shall be entitled to
designate and appoint or nominate such person’s successor in accordance with this Agreement and the Board shall promptly fill the vacancy with such successor CCP Director; provided, that, for the avoidance of doubt, the Charterhouse
Parties shall have no obligation to fill any such vacancy. 
 Section 1.02.    Certain Limitations.
Notwithstanding the provisions of Section 1.01, the Charterhouse Parties shall not be entitled to designate a person as the CCP Director upon a written determination by the Board or relevant committee thereof that the person would not be
qualified under any applicable law, rule or regulation to serve as a director of the Company. 
 ARTICLE 2 

MISCELLANEOUS 

Section 2.01.    Termination. This Agreement shall terminate and become void and of no further force or
effect: (i) automatically and without any notice or other action by any person on the first date that the Charterhouse Parties, collectively with their respective affiliates, hold less than 5.0% of the then-outstanding common stock of the
Company; or (ii) upon the mutual written agreement of the parties. 
 Section 2.02.    Notices. Any
notice or communication under this Agreement must be in writing and given by mail, hand delivery, electronic mail or facsimile. Each notice or communication that is mailed, delivered or transmitted in the manner described above shall be deemed
sufficiently given, served, sent and received, in the case of mailed notices, on the third business day following the date on which it is mailed and, in the case of notices delivered by hand delivery, electronic mail or facsimile, at such time as it
is delivered to the addressee or at such time as delivery is refused by the addressee upon presentation: 
 Any notice or communication under this Agreement
must be addressed: 
 if to the Company, to: 
 Mirion
Technologies, Inc. 
 1218 Menlo Drive 

  
 2 

 Atlanta, GA 30318 

Attention: General Counsel 
 Email: elee@mirion.com;
legal@mirion.com 
 with a copy (which copy shall not constitute notice) to: 

Davis Polk & Wardwell LLP 
 1600 El Camino Real Ste. 100

 Menlo Park, California 94025 
 Attention: Alan F. Denenberg,
Stephen Salmon, Bryan M. Quinn 
 E-mail: alan.denenberg@davispolk.com; stephen.salmon@davispolk.com; 

bryan.quinn@davispolk.com 
 if to the Charterhouse Parties, to:

 The Charterhouse Parties 
 6th Floor, Belgrave House, 76
Buckingham Palace Road 
 London, SW1W 9TQ, United Kingdom 

Attention: Christopher Warren, Thomas Patrick 
 E-mail: chris.warren@charterhouse.co.uk; tom.patrick@charterhouse.co.uk 
 with copies (which copies shall not constitute
notice) to: 
 Freshfields Bruckhaus Deringer US LLP 
 601
Lexington Avenue, 31st Floor 
 New York, New York 10019 

Attention: Valerie Ford Jacob 

E-mail: valerie.jacob@freshfields.com 

Freshfields Bruckhaus Deringer LLP 
 9 avenue de Messin 

75008 Paris, France 
 Attention: Yann Gozal 

E-mail: yann.gozal@freshfields.com 

Freshfields Bruckhaus Deringer LLP 
 100 Bishopsgate 

London EC2P 2SR, United Kingdom 
 Attention: Charles Hayes 

E-mail: charles.hayes@freshfields.com 

Section 2.03.    Severability. If any term or other provision of this Agreement is invalid, illegal or
incapable of being enforced by any rule of law or public policy, all other terms, conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the transactions
contemplated by this Agreement is not affected in any manner materially adverse to any party hereto. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto

  
 3 

 
shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties hereto as closely as possible in a mutually acceptable manner in order that the
Transactions contemplated by this Agreement be consummated as originally contemplated to the fullest extent possible. 

Section 2.04.    Binding Effect; Assignment. This Agreement and all of the provisions hereof shall be binding
upon and shall inure to the benefit of the parties hereto and their respective successors and permitted assigns. Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned, directly or indirectly, including by
operation of law, by any party hereto without the prior written consent of the other party hereto. 

Section 2.05.    No Third Party Beneficiaries. This Agreement is exclusively for the benefit of the parties
hereto, and their respective successors and permitted assigns, and this Agreement shall not be deemed to confer upon or give to any other third party any remedy, claim, liability, reimbursement, cause of action or other right by virtue of any
applicable law in any jurisdiction to enforce any of the terms to this Agreement. 
 Section 2.06.    Entire
Agreement. This Agreement constitutes the entire agreement among the parties with respect to the subject matter of this Agreement and supersedes all other prior agreements and understandings, both written and oral, between the parties with
respect to the subject matter of this Agreement. Each party hereto acknowledges and agrees that, in entering into this Agreement, such party has not relied on any promises or assurances, written or oral, that are not reflected in this Agreement.

 Section 2.07.    Governing Law. This Agreement, and all claims or causes of action based upon, arising
out of, or related to this Agreement or the transactions contemplated hereby, shall be governed by, and construed in accordance with, the laws of the State of Delaware, without giving effect to principles or rules of conflict of laws to the extent
such principles or rules would require or permit the application of laws of another jurisdiction. 

Section 2.08.    Jurisdiction. The parties hereto agree that any suit, action or proceeding seeking to enforce
any provision of, or based on any matter arising out of or in connection with, this Agreement or the transactions contemplated hereby shall be brought in the Court of Chancery of the State of Delaware or, if such court does not have jurisdiction, to
the Superior Court of the State of Delaware or, if jurisdiction is vested exclusively in federal courts of the United States, the federal courts of the United States sitting in the State of Delaware, so long as one of such courts shall have subject
matter jurisdiction over such suit, action or proceeding, and that any cause of action arising out of this Agreement shall be deemed to have arisen from a transaction of business in the State of Delaware, and each of the parties hereby irrevocably
consents to the jurisdiction of such courts (and of the appropriate appellate courts therefrom) in any such suit, action or proceeding and irrevocably waives, to the fullest extent permitted by law, any objection that it may now or hereafter have to
the laying of the venue of any such suit, action or proceeding in any such court or that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum. Process in any such suit, action or proceeding may be
served on any party anywhere in the world, whether within or without the jurisdiction of any such court. Without limiting the foregoing, each party agrees that service of process on such party as provided in Section 2.02 shall be deemed
effective service of process on such party. 

  
 4 

 Section 2.09.    WAIVER OF TRIAL BY JURY. EACH OF THE
PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY ACTION OR LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT. 

Section 2.10.    Specific Performance. The parties hereto agree that irreparable damage would occur if any
provision of this Agreement were not performed in accordance with the terms hereof and that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement or to enforce specifically the performance of the terms
and provisions hereof, in addition to any other remedy to which they are entitled at law or in equity. 

Section 2.11.    Counterparts. This Agreement may be executed in multiple counterparts, each of which shall be
deemed an original, and all of which together shall constitute the same instrument, but only one of which need be produced. Counterparts may be delivered via facsimile, electronic mail (including any electronic signature covered by the U.S. federal
ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method, and any counterpart so delivered shall be deemed to have been duly and
validly delivered and be valid and effective for all purposes. 
 Section 2.12.    Amendment; Waiver. Any
provision of this Agreement may be amended or waived if, but only if, such amendment or waiver is in writing and is signed, in the case of an amendment, by each party to this Agreement or, in the case of a waiver, by each party against whom the
waiver is to be effective. 
 Section 2.13.    Rights Cumulative. No failure or delay by any party in
exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. Except as
otherwise expressly limited by this Agreement, all rights and remedies of each of the parties hereto under this Agreement will be cumulative, and the exercise of one or more rights or remedies will not preclude the exercise of any other right or
remedy available under this Agreement or law. 
 Section 2.14.    Further Assurances. Each of the parties
hereto shall execute and deliver such further instruments and do such further acts and things as may be required to carry out the intent and purpose of this Agreement. 

Section 2.15.    Headings. The headings herein are for convenience only, do not constitute a part of this
Agreement and shall not be deemed to limit or affect any of the provisions hereof. 
 [Signature Page Follows] 

  
 5 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as a
deed as of the date first written above. 
  

			
	MIRION TECHNOLOGIES, INC.
		
	By:	 	  

		 	Name:
		 	Title:

 [Signature Page to Director Nomination Agreement] 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as a
deed as of the date first written above. 
  

			
	CCP IX LP NO. 1, acting by its General
Partner, CHARTERHOUSE GENERAL 
PARTNERS (IX) LIMITED
		
	By:	 	  

		 	Name:
		 	Title:

  

			
	CCP IX LP NO. 2, acting by its General
Partner, CHARTERHOUSE GENERAL 
PARTNERS (IX) LIMITED
		
	By:	 	  

		 	Name:
		 	Title:

  

			
	CCP IX CO-INVESTMENT LP, acting by
its General Partner, CHARTERHOUSE
GENERAL PARTNERS (IX) LIMITED
		
	By:	 	  

		 	Name:
		 	Title:

  

			
	CCP IX CO-INVESTMENT NO. 2 LP,
acting by its General Partner,
CHARTERHOUSE GENERAL PARTNERS (IX) LIMITED
		
	By:	 	  

		 	Name:
		 	Title:

 [Signature Page to Director Nomination Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}]]